Market Tracker

01/23 6:05pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

9.59
Data as of Jan 23
 -0.23 / -2.34%
Today’s Change
4.13
Today|||52-Week Range
12.00
-15.13%
Year-to-Date

Today’s Trading

Previous close9.82
Today’s open9.72
Day’s range9.50 - 9.81
Volume1,448,337
Average volume (3 months)1,951,899
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 01/23/2015

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+34.85%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S-0.07-0.32%
ARNAArena Pharmaceutical...-0.11-2.36%
TTPHTetraphase Pharmaceu...-1.23-3.53%
SAGESAGE Therapeutics In...-0.30-0.78%
Data as of 4:00pm ET, 01/23/2015

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts